Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Small Cell Lung Carcinoma 1Rectal Neoplasms 1Pancreatic Neoplasms 1Lung Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms, Male 1

Interventions

pembrolizumab 6Gemcitabine 6Psychiatric Rehabilitation 5Early Intervention, Educational 5Cisplatin 5Cetuximab 5cediranib 4Oxaliplatin 4Magnetic Resonance Spectroscopy 4Leucovorin 4Fluorouracil 4Carboplatin 4Bevacizumab 4Trastuzumab 3Standard of Care 3Radiotherapy 3Pemetrexed 3Paclitaxel 3Methods 3Irinotecan 3Erlotinib Hydrochloride 3Docetaxel 3trametinib 2X-Rays 2Specimen Handling 2Mental Status and Dementia Tests 2Interleukin-12 Subunit p35 2Fluorodeoxyglucose F18 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × denileukin diftitox × Thoracic × Clear all
NCT00128622 2012-11-12

Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer

Duke University

Phase 1 Completed
24 enrolled
BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Breast Neoplasms, Male, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡